Subacute anthracycline cardiotoxicity

Heart Lung and Circulation

Volumn 15, Issue 1, 2006, Pages 59-61

  Hengel, Christopher L ^a   Russell, Prudence A ^a   Gould, Paul A ^a   Kaye, David M ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Anthracycline; Echocardiography; Myocardial disease; Toxicity

Indexed keywords

AMPHOTERICIN; ANTHRACYCLINE; C REACTIVE PROTEIN; CIPROFLOXACIN; CYTARABINE; IDARUBICIN; TROPONIN I; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD FLOW VELOCITY; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CASE REPORT; CELL INFILTRATION; CORONARY ARTERY BLOOD FLOW; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; GRAM NEGATIVE SEPSIS; HEART CONTRACTION; HEART EDEMA; HEART MUSCLE BIOPSY; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MYOCARDITIS; NEUTROPENIA; PERICARDITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 33644825008     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2005.06.003     Document Type: Article

References (8)

1. Wojtacki J, Lewicka-Nowak E, Lesniewski-Kmak K Anthracycline-induced cardiotoxicity. clinical course, risk factors, pathogenesis, detection and prevention - review of the literature. Med Sci Monit 2000;6:411-20.
2. Bristow MR, Billingham ME, Mason JW, Daniels JR. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 1978;62:873-9.
3. Gaudin PB, Hruban RH, Beschorner WE, Kasper EK, Olson JL, Baughman KL, et al. Myocarditis associated with doxorubicin cardiotoxicity. Am J Clin Pathol 1993;100:158-63.
4. Seifert CF, Nesser ME, Thompson DF. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann Pharmacother 1994;28:1063-72.
5. Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 2004;110:2869-74.
6. Fogli S, Nieri P, Breschi MC. The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J 2004;18:664-75.
7. Zsary A, Szucs S, Keltai K, Schneider T, Rosta A, Sarman P, et al. Endothelins: a possible mechanism of cytostatics-induced cardiomyopathy. Leuk Lymphoma 2004;45:351-5.
8. Kapusta L, Thijssen JM, Groot-Loonen J, van Druten JA, Daniels O. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines. Ultrasound Med Biol 2001;27:1605-14.